🟢 ProMIS Neurosciences is trading 5% up today ahead of September 15, 2026 H.C. Wainwright presentation

ProMIS Neurosciences is trading at $13.93 (+5.05%) ahead of its scheduled September 15, 2026 H.C. Wainwright presentation at 10:30 a.m. ET.

• The company is expected to discuss PMN310 and its PRECISE-AD Phase 1b program.
• Investor interest may reflect previously reported interim data showing zero ARIA-E cases, no treatment-related serious adverse events, and a 15% p-tau217 reduction.
• Biotech and major indexes are lower; no separate September 15 filing, analyst action, or trial update was found.